Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.

Marcsisin SR, Engen JR.

J Mol Biol. 2010 Oct 8;402(5):892-904. doi: 10.1016/j.jmb.2010.08.026. Epub 2010 Aug 20.

2.

The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.

Bergeron JR, Huthoff H, Veselkov DA, Beavil RL, Simpson PJ, Matthews SJ, Malim MH, Sanderson MR.

PLoS Pathog. 2010 Jun 3;6(6):e1000925. doi: 10.1371/journal.ppat.1000925.

3.

Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction.

Lu Z, Bergeron JR, Atkinson RA, Schaller T, Veselkov DA, Oregioni A, Yang Y, Matthews SJ, Malim MH, Sanderson MR.

Open Biol. 2013 Nov 13;3(11):130100. doi: 10.1098/rsob.130100.

4.

Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.

Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T.

J Biol Chem. 2005 May 13;280(19):18573-8. Epub 2005 Mar 21.

5.

Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.

Zhou X, Evans SL, Han X, Liu Y, Yu XF.

PLoS One. 2012;7(3):e33495. doi: 10.1371/journal.pone.0033495. Epub 2012 Mar 30.

6.

On the solution conformation and dynamics of the HIV-1 viral infectivity factor.

Marcsisin SR, Narute PS, Emert-Sedlak LA, Kloczewiak M, Smithgall TE, Engen JR.

J Mol Biol. 2011 Jul 29;410(5):1008-22. doi: 10.1016/j.jmb.2011.04.053.

7.

Dissection of the HIV Vif interaction with human E3 ubiquitin ligase.

Wolfe LS, Stanley BJ, Liu C, Eliason WK, Xiong Y.

J Virol. 2010 Jul;84(14):7135-9. doi: 10.1128/JVI.00031-10. Epub 2010 May 12.

8.

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.

Zhang W, Du J, Evans SL, Yu Y, Yu XF.

Nature. 2011 Dec 21;481(7381):376-9. doi: 10.1038/nature10718.

PMID:
22190036
9.

Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.

Fribourgh JL, Nguyen HC, Wolfe LS, Dewitt DC, Zhang W, Yu XF, Rhoades E, Xiong Y.

J Virol. 2014 Mar;88(6):3309-19. doi: 10.1128/JVI.03824-13. Epub 2014 Jan 3.

10.

Structural insights for HIV-1 therapeutic strategies targeting Vif.

Salter JD, Morales GA, Smith HC.

Trends Biochem Sci. 2014 Sep;39(9):373-80. doi: 10.1016/j.tibs.2014.07.001. Epub 2014 Aug 12. Review.

11.

Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.

Zhang W, Wang H, Li Z, Liu X, Liu G, Harris RS, Yu XF.

J Virol. 2014 Nov;88(21):12528-40. doi: 10.1128/JVI.02072-14. Epub 2014 Aug 20.

12.

Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

Wang X, Wang X, Zhang H, Lv M, Zuo T, Wu H, Wang J, Liu D, Wang C, Zhang J, Li X, Wu J, Yu B, Kong W, Yu X.

Retrovirology. 2013 Aug 29;10:94. doi: 10.1186/1742-4690-10-94.

13.

Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex.

Salter JD, Lippa GM, Belashov IA, Wedekind JE.

Biochemistry. 2012 Nov 6;51(44):8702-4. doi: 10.1021/bi301244z. Epub 2012 Oct 25.

14.

Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Matsui Y, Shindo K, Nagata K, Io K, Tada K, Iwai F, Kobayashi M, Kadowaki N, Harris RS, Takaori-Kondo A.

Virology. 2014 Jan 20;449:82-7. doi: 10.1016/j.virol.2013.11.004. Epub 2013 Nov 26.

15.

CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.

Kim DY, Kwon E, Hartley PD, Crosby DC, Mann S, Krogan NJ, Gross JD.

Mol Cell. 2013 Feb 21;49(4):632-44. doi: 10.1016/j.molcel.2012.12.012. Epub 2013 Jan 17.

16.

Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB.

da Costa KS, Leal E, dos Santos AM, Lima e Lima AH, Alves CN, Lameira J.

PLoS One. 2014 Feb 26;9(2):e89116. doi: 10.1371/journal.pone.0089116. eCollection 2014.

17.

Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Ai Y, Zhu D, Wang C, Su C, Ma J, Ma J, Wang X.

J Virol. 2014 Oct;88(20):12112-22. doi: 10.1128/JVI.01924-14. Epub 2014 Aug 13.

18.

Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.

Bullock AN, Debreczeni JE, Edwards AM, Sundström M, Knapp S.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7637-42. Epub 2006 May 4.

19.
20.

Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.

Guo Y, Dong L, Qiu X, Wang Y, Zhang B, Liu H, Yu Y, Zang Y, Yang M, Huang Z.

Nature. 2014 Jan 9;505(7482):229-33. doi: 10.1038/nature12884.

PMID:
24402281

Supplemental Content

Support Center